Wednesday, January 14, 2015

The Construction of scFv/Fab


What You Need to Know About scFv/Fa
 
Fragment antigen-binding (Fab fragment) is a region on an antibody that binds to antigens. It is composed of one constant and one variable domain of each of the heavy and the light chain. Single-chain variable fragment (scFv) is not actually a fragment of an antibody, but instead is a fusion protein of the variable regions of the heavy (VH) and light chains (VL) of immunoglobulins, connected with a short linker peptide of ten to about 25 amino acids.

Fab fragments differ from scFv's as they contain both variable domains and constant regions, thus are more complex in construction and ultimate expression. Creative Biolabs is an expert with many years of experiences in antibody production. It has established a solid platform for scFv and Fab constuction. The same heavy and light variable chains used for scFv construction can also be used in the construction of Fab.

There are three routes to have a scFv or Fab target a specific antigen in Creative Biolabs. The first approach is to generate a mouse hybridoma clone, then convert full IgG [or IgM] into a scFv or Fab; the second one is to create an immunized phage display scFv or Fab mouse library, then use the antigen to screen the library; the third method is to use the antigen to screen a premade scFv or Fab antibody phage display library [usually a human one] to get scFv or Fab clones directly. We are also able to convert chicken IgY into scFv or Fab fragments.

In Creative Biolabs, customers will experience professional and high-qualified scFv/Fab Construction services. To learn more about the procedures, please visit creative-biolabs.com

Monday, January 12, 2015

In Situ Hybridization – An Up-rising Star in the Field of Biology



In situ hybridization (ISH) may not be a new phrase for today’s Biological world. It has not been in this industry for long, but its promising future, without any doubt, is recognized by increasing biologists and institutions.

In situ hybridization (ISH) is a technology being made up of combinations of molecular biology, histochemistry and cytology. Gall from Yale University together with other biologists’ crossing the Xenopus laevis ribosomal genes with its oocyte and mapping the product in 1969, along with Buongiorno Nardell and Amaldi’s mapping the gene of the cell and tissue with isotope-labeled nucleic acid probe in 1970 gave birth to the primitive ISH. As molecular biological technology developed rapidly latter on, especially in the end of 1970s and at the beginning of 1980s when molecular cloning, plasmid and phage DNA were successfully constructed, profound technical foundation were laid to ISH.

In order to support this new technology, many institutions have themselves involved in it. In Creative BioLabs, Customers can experience the most considerable in situ hybridization (ISH) service. They offer a full array of custom in situ hybridization (ISH) service from probe design, tissue acquisition to expert interpretation of gene expression results.

Featured services of Creative Biolabs include template preparation, probe design, labeling and purification, preparation of tissue, pilot hybridization, hybridization and result interpretation. To know more about accurate and reliable In Situ Hybridization procedures, please visit creative-biolabs.com.

Tuesday, November 18, 2014

Technological Breakthrough on Creative Biolabs’ Yeast Display Services


Yeast display is a protein engineering technique widely used for in vitro protein evolution. Libraries of polypeptides displayed on the surface of yeast are screened using flow cytometry. Yeast is superior to phage for human antibody display in that the eukaryotic expression environment of yeast cells is more suitable for human protein folding, modification and translocation for display. Therefore, the yeast displayed antibodies are conformationally and functionally more close to human native counterparts.

Creative BioLabs has achieved a breakthrough of unique yeast display technology (UltraffTM) for updating its Yeast Display Services. It invented UltraffTM Yeast Display Technology as a novel technology for discovery and affinity maturation of fragment antibody, i.e., scFv and Fab, through the screening of an antibody library displayed on yeast surface.

The advantage of UltraffTM Yeast Display Technology is that antigen-binding yeast cell population can be easily sorted using Fluorescence Assisted Cell Sorting (FACS). This enables yeast display very efficient for affinity maturation because in additional to the antigen concentration management and stringent washing used in phage display, FACS is more efficient in direct sorting of higher affinity populations.

Creative Biolabs is also proud of a proprietary yeast transformation technique that guarantees up to 2×108transformants per transformation. Previously, the low transformation efficiency of yeast cells significantly restrained the utilization of yeast display for antibody discovery. A typical efficiency of 105 transformants per transformation was nearly impossible to yield large size (>109) libraries, which in turn, were hard to give rise to high affinity antibodies due to the limited diversity.With this yeast cell transformation technique, UltraffTM Yeast Display Technology is now very efficient for high-affinity antibody discovery and antibody affinity maturation.
Want to know more? Click creative-biolabs.com for more leading-edge biotechnologies.

This is written by Victoria, the editor of Creative Biolabs, a leading custom service provider that is expert in conducting yeast display as well as other discovery services.